文献速递心律失常心力衰竭与心肌病冠心病

Circulation 系列期刊亮点汇总

Highlights From the Circulation Family of Journals.
PubMed 文献 · Circulation · 2021-01-25

本期亮点覆盖心房颤动、微血管功能障碍、动脉粥样硬化进展、卒中质量改进及 DAPA-HF 亚分析;包括人工智能算法预测房颤、根据遗传易感性评估饮酒与房颤关联、雷诺嗪治疗微血管功能障碍的随机试验、基线 18F-氟化钠 PET 活性与冠脉钙化的关联、美国心脏协会 Target: Stroke 质量改进项目,以及达格列净在 DAPA-HF 不同心衰病程队列中的获益亚组分析。

要点

  • AI 算法应用于窦性心律心电图可独立预测心房颤动。
  • 饮酒与房颤的关联按房颤遗传易感性评估。
  • 达格列净在 DAPA-HF 不同心衰病程队列中获益。

核心结论

  • 本期系列期刊亮点涵盖房颤预测、微血管功能障碍治疗、动脉粥样硬化进展、卒中质量改进及 DAPA-HF 亚分析等多个方向。

研究设计与样本

  • 应用人工智能算法分析窦性心律心电图的研究来自 Circulation: Arrhythmia and Electrophysiology。
  • 按房颤遗传易感性评估饮酒与房颤关联的研究来自 Circulation: Genomic and Precision Medicine。
  • 雷诺嗪治疗微血管功能障碍的随机试验来自 Circulation: Cardiovascular Interventions。
  • 基线 18F-氟化钠 PET 活性与冠脉钙化关联的研究来自 Circulation: Cardiovascular Imaging。
  • 美国心脏协会 Target: Stroke 质量改进项目来自 Circulation: Cardiovascular Quality and Outcomes。

主要发现

  • 人工智能算法应用于窦性心律心电图可独立预测心房颤动。
  • 基线 18F-氟化钠 PET 活性与 incident 冠脉钙化相关。
  • DAPA-HF 亚研究评估达格列净在不同心衰病程队列中的获益。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

This month's highlights from the subspecialty journals cover atrial fibrillation, microvascular dysfunction, progression of atherosclerosis, a stroke quality initiative, and a subanalysis of DAPAHF (Study to Evaluate the Effect of Dapagliflozin on the Incidence of Worsening Heart Failure or Cardiovascular Death in Patients With Chronic Heart Failure). Applying an artificial intelligence algorithm to sinus rhythm ECGs independently predicts atrial fibrillation in a study from Circulation: Arrhythmia and Electrophysiology. In Circulation: Genomic and Precision Medicine, the association of alcohol intake with atrial fibrillation was evaluated according to genetic predisposition to atrial fibrillation. In Circulation: Cardiovascular Interventions, a randomized trial of ranolazine treatment for microvascular dysfunction is reported. In Circulation: Cardiovascular Imaging, baseline 18F-sodium florid activity by positron emission tomography was associated with incident coronary calcification. The Target: Stroke quality initiative from the American Heart Association is reported in Circulation: Cardiovascular Quality and Outcomes. A substudy in Circulation: Heart Failure evaluates the benefit of dapagliflozin across cohorts of duration of heart failure from DAPA-HF.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Highlights From the Circulation Family of Journals. Circulation. 2021. PMID: 33493028. doi:10.1161/CIRCULATIONAHA.120.053435

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。